FDAnews
www.fdanews.com/articles/132293-immunogen-starts-trial-of-lung-cancer-drug

ImmunoGen Starts Trial of Lung Cancer Drug

November 30, 2010
ImmunoGen Inc. said it has initiated a randomized Phase I/II clinical trial to evaluate its proprietary product candidate, IMGN901, for first-line treatment of small-cell lung cancer in patients with extensive disease.
boston